Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
2021/06/04 by Suowen Xu, Iqra Ilyas, Peter J. Little +12 · 1,119 citations
Immunology and Microbiology · Medicine · #Adipokines, Inflammation, and Metabolic Diseases #Angiogenesis #Atherosclerosis and Cardiovascular Diseases #Bioinformatics #Biology #Cancer research #Endothelial dysfunction #Endothelial stem cell #Endothelium #Immunology #Inflammation #Internal medicine #Medicine #Neutrophil, Myeloperoxidase and Oxidative Mechanisms #Pharmacology
paper · pdf · doi:10.1124/pharmrev.120.000096
published in Pharmacological Reviews 73(3), 924-967 (American Society for Pharmacology and Experimental Therapeutics)
openalex publication_date 2021/06/04 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/05
Citations
Cited by
- Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications
- Three hours of targeted limb passive heating increases conduit artery shear rates and lowers vascular stiffness
- HIV infection, antiretroviral therapy and vascular dysfunction: Effects, mechanisms and treatments
- Sodium Danshensu alleviates oxidative stress-induced endothelial apoptosis and senescence by modulating the SIRT1/p53 pathway
- Oxidative stress and obesity are associated with endothelial dysfunction and subclinical atherosclerosis in adolescents
- Endothelial Dysfunction and Cardiovascular Disease: History and Analysis of the Clinical Utility of the Relationship. [europepmc]
- The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. [europepmc]
- Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function. [europepmc]
- NLRP3 Activation and Its Relationship to Endothelial Dysfunction and Oxidative Stress: Implications for Preeclampsia and Pharmacological Interventions. [europepmc]
- Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment. [europepmc]
- Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications. [europepmc]
- Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis. [europepmc]
- Resveratrol in Treating Diabetes and Its Cardiovascular Complications: A Review of Its Mechanisms of Action. [europepmc]
- Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. [europepmc]
- From Iron Metabolism to Ferroptosis: Pathologic Changes in Coronary Heart Disease. [europepmc]
- Hypertension, Neurovascular Dysfunction, and Cognitive Impairment. [europepmc]
- Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. [europepmc]
- Brown adipose tissue-derived Nrg4 alleviates endothelial inflammation and atherosclerosis in male mice. [europepmc]
- Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction. [europepmc]
- SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common ALDH2 alcohol flushing variant. [europepmc]
- Oxidative Stress, Antioxidants and Hypertension. [europepmc]
- Endothelial Cell Dysfunction and Increased Cardiovascular Risk in Patients With Chronic Kidney Disease. [europepmc]
- Endothelial mechanobiology in atherosclerosis. [europepmc]
- Metabolite Neu5Ac triggers SLC3A2 degradation promoting vascular endothelial ferroptosis and aggravates atherosclerosis progression in ApoE -/- mice. [europepmc]
- Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. [europepmc]
- Integrative single-cell meta-analysis reveals disease-relevant vascular cell states and markers in human atherosclerosis. [europepmc]
- Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus. [europepmc]
- Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications. [europepmc]
- ASF1A-dependent P300-mediated histone H3 lysine 18 lactylation promotes atherosclerosis by regulating EndMT. [europepmc]
- The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma. [europepmc]